ANTIMULLARIAN HORMONE VARIATION THROUGHOUT THE MENSTRUAL CYCLE

This prospective cross-sectional study is to assess the Anti-Mullerian hormone variation throughout the menstrual cycle in the number of women suffering from subfertility and attending the Basrah Fertility Center at Basrah Maternity and Children Hospital. This study was conducted at Basrah Maternity...

Full description

Bibliographic Details
Main Authors: Ali Falih Al-Assadi, Huda Abbas Jabbar AL.Sharae, Wafaa Sami, Safa Kifah
Format: Article
Language:English
Published: university of basrah 2022-06-01
Series:Basrah Journal of Surgery
Subjects:
Online Access:https://www.iasj.net/iasj/pdf/75d30cb09c78a7cd
Description
Summary:This prospective cross-sectional study is to assess the Anti-Mullerian hormone variation throughout the menstrual cycle in the number of women suffering from subfertility and attending the Basrah Fertility Center at Basrah Maternity and Children Hospital. This study was conducted at Basrah Maternity and Children Hospital (Basrah city, south of Iraq) during the period from February 2019 to July 2020.The participants had not used combined oral contraceptive (COC) or being pregnant or breastfeeding for at least 2 months before the study cycle; midcycle was identified by subtracting 14 days from the mean cycle length. Fifty participants were included in this study; they were assessed using specially designed questionnaire. From each attendance 3 blood samples were taken for Anti-mullerian measurment, the first at the early follicular phase, the second one at the midcycle, and the third at the mid-luteal phase of the menstrual cycle. Of our fifty participants, 64% were from the age group (20-29) year and 36% were from the age group (30-40) year.4% were underweight,40% were normal weight,32% were overweight and 24% were obese.62% were complaining of primary subfertility and 38% were with secondary subfertility.26% were employed, and 74% were housewives. There were statistically significant differences between AMH1 (early follicular phase) and AMH2 (midcycle) (p-value 0.0001) and between AMH2 and AMH3 (mid-luteal phase) (p-value 0.004), whereas there was no statistically significant difference between AMH1 and AMH3. In conclusion, there is a significant intracyclic variation in the level of AMH and which tend to be lower at the midcycle phase.
ISSN:1683-3589
2409-501X